
AI drug discovery platform for neurotherapeutics
screenshot pendingExin Therapeutics is a biotechnology company focused on developing a target discovery platform specifically for neurotherapeutics that aim to address various neural circuit disorders. The company leverages advanced artificial intelligence to predict the potential of drug candidates across multiple neural disorders simultaneously. This innovative approach allows for the identification of next-generation neurotherapeutics that can effectively target these complex conditions.